Recent Senate hearings have spotlighted the nominations for top health positions, including Trump’s pick for Surgeon General, Nicole Saphier. Notably, Chris Klomp, nominated for the Deputy Secretary of HHS, faced tough questioning from Democrats regarding his stance on vaccines and drug pricing contracts. In contrast to RFK Jr., Klomp openly endorsed the measles vaccine, deeming the fight against outbreaks a ‘top priority.’ As the Senate scrutinizes these nominees, controversies abound including allegations of tax dodging and concerns regarding drug-price deals tied to the Trump administration. The hearings have also seen a strong focus on the health policies and priorities of the incoming officials, setting the stage for potential shifts in public health strategy in the U.S.